PROGRAMME OVERVIEW
Keynote Speakers
enlarge
David Brooks
David Brooks is Hartnett Professor of Neurology and Head of the Department of Clinical Neuroscience in the Division of Experimental Medicine, Imperial College, London, UK. He is also Head of the Neurology Group at the Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, London. His research involves the use of positron emission tomography and magnetic resonance imaging to study the biochemical and pharmacological changes that occur in Alzheimer’s and Parkinson’s diseases and as biomarkers to assess the efficacy of novel therapeutics.
enlarge
Vic Pike
Vic Pike is a Senior Investigator at the Molecular Imaging Branch of the National Institute of Mental Health (Bethesda, USA), and Chief of the PET Radiopharmaceutical Sciences Section. The core scientific interest of this Section is to discover and evaluate new radiotracers for imaging specific molecular targets (neurotransmitter receptors, transporters or enzymes) in animal and human brain with PET for eventual application in neuropsychiatric research. Radiotracers for TSPO sites, mGluR5, CB1 receptors and P-gp have recently been developed and are in use for clinical studies.
